• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于检测终末期肾病潜在生物标志物的尿液蛋白质组学

Urine Proteomics for Detection of Potential Biomarkers for End-Stage Renal Disease.

作者信息

Silva Nathalia R, Picolo Bianca U, de Sousa Letícia C M, Dos Santos Marta S, Polveiro Richard C, Almeida-Souza Hebréia O, Martins Mário M, Goulart Filho Luiz R, da Silva Luciana S

机构信息

Faculty of Medicine, Federal University of Uberlândia, Uberlândia 38402-293, Brazil.

Nanobiotechnology Laboratory Prof. Luiz Ricardo Goulart Filho, Institute of Biotechnology, Federal University of Uberlândia, Uberlândia 38405-319, Brazil.

出版信息

Int J Mol Sci. 2025 Jun 6;26(12):5429. doi: 10.3390/ijms26125429.

DOI:10.3390/ijms26125429
PMID:40564893
Abstract

The increasing number of individuals with chronic kidney disease (CKD), mainly due to lifestyle changes-such as increased consumption of processed foods, physical inactivity, obesity, and smoking habits-and population aging, highlights the need to identify new biomarkers to facilitate monitoring of CKD progression and, consequently, predict end-stage renal disease (ESRD). This study aimed to analyze the proteomic profile of urine samples from healthy individuals and those with ESRD to identify potential biomarkers for this advanced stage of CKD. Urine samples were collected from 20 participants, comprising 10 healthy individuals and 10 patients with ESRD, and analyzed via liquid chromatography coupled with a tandem mass spectrometer. Bioinformatics analyses, including gene ontology and protein interaction, were subsequently conducted. A total of 416 proteins were identified in the proteomic profiles of the groups, and 19 proteins showed statistically significant differences between them. Of these, five proteins-hemopexin, beta-2-microglobulin, retinol-binding protein 4, transthyretin, and factor D-emerged as potential biomarkers for ESRD. The proteins identified were able to characterize and differentiate the urinary proteomic profiles of the two groups. The five selected proteins represent promising candidates for ESRD biomarkers.

摘要

慢性肾脏病(CKD)患者数量不断增加,主要归因于生活方式的改变,如加工食品消费增加、缺乏体育锻炼、肥胖和吸烟习惯,以及人口老龄化。这凸显了识别新生物标志物以促进监测CKD进展并进而预测终末期肾病(ESRD)的必要性。本研究旨在分析健康个体和ESRD患者尿液样本的蛋白质组学特征,以识别CKD这一晚期阶段的潜在生物标志物。从20名参与者中收集尿液样本,其中包括10名健康个体和10名ESRD患者,并通过液相色谱与串联质谱仪进行分析。随后进行了包括基因本体论和蛋白质相互作用在内的生物信息学分析。在两组的蛋白质组学特征中共鉴定出416种蛋白质,其中19种蛋白质在两组之间表现出统计学上的显著差异。其中,血色素结合蛋白、β-2-微球蛋白、视黄醇结合蛋白4、转甲状腺素蛋白和补体因子D这五种蛋白质成为ESRD的潜在生物标志物。所鉴定的蛋白质能够表征和区分两组的尿液蛋白质组学特征。所选的这五种蛋白质是ESRD生物标志物的有前景的候选物。

相似文献

1
Urine Proteomics for Detection of Potential Biomarkers for End-Stage Renal Disease.用于检测终末期肾病潜在生物标志物的尿液蛋白质组学
Int J Mol Sci. 2025 Jun 6;26(12):5429. doi: 10.3390/ijms26125429.
2
Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.早期转介策略在管理有肾脏疾病标志物的人群中的应用:对临床有效性、成本效益和经济分析证据的系统评价。
Health Technol Assess. 2010 Apr;14(21):1-184. doi: 10.3310/hta14210.
3
Comparison of cellulose, modified cellulose and synthetic membranes in the haemodialysis of patients with end-stage renal disease.纤维素、改性纤维素和合成膜在终末期肾病患者血液透析中的比较。
Cochrane Database Syst Rev. 2001(3):CD003234. doi: 10.1002/14651858.CD003234.
4
Integrated Plasma and Tumor Proteomics of Nasopharyngeal Carcinoma in a Moroccan Cohort.摩洛哥队列中鼻咽癌的综合血浆和肿瘤蛋白质组学
Int J Mol Sci. 2025 Jun 16;26(12):5771. doi: 10.3390/ijms26125771.
5
Age and gender differences in the urinary proteome of healthy subjects using the advantages of quantitative proteomics.利用定量蛋白质组学的优势研究健康受试者尿液蛋白质组中的年龄和性别差异。
Clin Exp Nephrol. 2025 Feb 24. doi: 10.1007/s10157-025-02639-2.
6
Are Urinary Tubular Injury Markers Useful in Chronic Kidney Disease? A Systematic Review and Meta Analysis.肾小管损伤标志物在慢性肾脏病中有用吗?一项系统评价和Meta分析。
PLoS One. 2016 Dec 1;11(12):e0167334. doi: 10.1371/journal.pone.0167334. eCollection 2016.
7
Recent Advances in Urinary Peptide and Proteomic Biomarkers in Chronic Kidney Disease: A Systematic Review.慢性肾脏病中尿肽和蛋白质组生物标志物的最新进展:系统评价。
Int J Mol Sci. 2023 May 23;24(11):9156. doi: 10.3390/ijms24119156.
8
Mass Spectrometry-Based Proteomics for Discovering Salivary Biomarkers in Periodontitis: A Systematic Review.基于质谱的蛋白质组学在牙周炎唾液生物标志物发现中的应用:一项系统综述
Int J Mol Sci. 2023 Sep 27;24(19):14599. doi: 10.3390/ijms241914599.
9
Development and Validation of a Capillary Electrophoresis Coupled to Mass Spectrometry Pipeline for Comparable Assessment of the Plasma Peptidome.用于血浆肽组可比评估的毛细管电泳-质谱联用方法的开发与验证
Proteomics. 2025 Jun;25(11-12):e202400114. doi: 10.1002/pmic.202400114. Epub 2025 Mar 16.
10
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.血管紧张素转换酶抑制剂和血管紧张素受体阻滞剂用于患有早期(1至3期)非糖尿病慢性肾病的成人。
Cochrane Database Syst Rev. 2011 Oct 5(10):CD007751. doi: 10.1002/14651858.CD007751.pub2.

本文引用的文献

1
Candidate protein biomarkers in chronic kidney disease: a proteomics study.慢性肾脏病的候选蛋白生物标志物:一项蛋白质组学研究。
Sci Rep. 2024 Jun 18;14(1):14014. doi: 10.1038/s41598-024-64833-8.
2
Chronic kidney disease and the global public health agenda: an international consensus.慢性肾脏病与全球公共卫生议程:国际共识。
Nat Rev Nephrol. 2024 Jul;20(7):473-485. doi: 10.1038/s41581-024-00820-6. Epub 2024 Apr 3.
3
KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease.KDIGO 2024慢性肾脏病评估与管理临床实践指南
Kidney Int. 2024 Apr;105(4S):S117-S314. doi: 10.1016/j.kint.2023.10.018.
4
Leukocyte-endothelial interaction in CKD.慢性肾脏病中的白细胞-内皮细胞相互作用
Clin Kidney J. 2023 Jun 8;16(11):1845-1860. doi: 10.1093/ckj/sfad135. eCollection 2023 Nov.
5
Recent Advances in Urinary Peptide and Proteomic Biomarkers in Chronic Kidney Disease: A Systematic Review.慢性肾脏病中尿肽和蛋白质组生物标志物的最新进展:系统评价。
Int J Mol Sci. 2023 May 23;24(11):9156. doi: 10.3390/ijms24119156.
6
Association of Urinary Biomarkers of Renal Tubular Injury with Cognitive Dysfunction in Older Patients with Chronic Kidney Disease: A Cross-Sectional Observational Study.老年慢性肾脏病患者肾小管损伤尿生物标志物与认知功能障碍的关联:一项横断面观察性研究
Brain Sci. 2023 Mar 25;13(4):551. doi: 10.3390/brainsci13040551.
7
High serum β2-microglobulin is a significant predictor of mortality in maintenance hemodialysis patients.血清β2-微球蛋白水平升高是维持性血液透析患者死亡的重要预测指标。
Semin Dial. 2023 May-Jun;36(3):247-254. doi: 10.1111/sdi.13128. Epub 2022 Nov 13.
8
The Clinical Significance of Urinary Retinol-Binding Protein 4: A Review.尿视黄醇结合蛋白 4 的临床意义:综述。
Int J Environ Res Public Health. 2022 Aug 11;19(16):9878. doi: 10.3390/ijerph19169878.
9
Interplay of retinol binding protein 4 with obesity and associated chronic alterations (Review).视黄醇结合蛋白 4 与肥胖及相关慢性改变的相互作用(综述)。
Mol Med Rep. 2022 Jul;26(1). doi: 10.3892/mmr.2022.12760. Epub 2022 Jun 3.
10
Epidemiology of chronic kidney disease: an update 2022.慢性肾脏病流行病学:2022年最新情况
Kidney Int Suppl (2011). 2022 Apr;12(1):7-11. doi: 10.1016/j.kisu.2021.11.003. Epub 2022 Mar 18.